Labiotech.eu

News and Trends 21 Jul 2022

Vicebio exits stealth to work on next generation RSV vaccine

Vicebio Ltd, a biopharmaceutical company founded by Medicxi in 2019, has launched to accelerate the development of novel vaccines against life-threatening respiratory viral infections using its molecular clamp technology platform. The technology has been developed by Paul Young, Daniel Watterson, Keith Chappell and their groups at The University of Queensland (UQ), Brisbane, Australia. It was […]

July 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

IVI and Moderna sign MOU for vaccine R&D

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotech company working on messenger RNA (mRNA) therapeutics and vaccines, have signed a Memorandum of Understanding (MOU) to partner on collaborative vaccine research and development. “IVI welcomes this […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

BigHat Biosciences raises $75M to design safer, more effective antibodies

A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series B funding round was led by Section 32 with participation from new investors Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, GRIDS Capital and others. […]

July 20, 2022 - 4 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Upstaza gets nod from Europe for AADC deficiency treatment

PTC Therapeutics, Inc. says Upstaza (eladocagene exuparvovec) has been given marketing authorization by the European Commission. Upstaza is the first approved disease-modifying treatment for aromatic L-amino acid decarboxylase (AADC) deficiency, and the first marketed gene therapy directly infused into the brain. It is approved for patients 18 months and older. “Today’s approval from the European […]

July 20, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

Iron protein can now be captured thanks to technology developed by NaviGo

An iron-storing protein can now be captured thanks to the successful development of a Precision Capturing affinity resin. Ferritin, an intracellular protein, is released into the bloodstream in small amounts where it acts as an iron carrier. Protein engineering company and developer of affinity ligands for custom chromatography solutions, NaviGo Proteins GmbH, announced today (July […]

July 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Plant-based nylon addressing urgent need for sustainable materials

Global brands need to take action by using sustainable materials with traceable and transparent supply chains, the CEO of a US biotech company says. Genomatica (Geno) alongside longtime collaborator Aquafil has just completed the first demonstration scale production runs for plant-based nylon-6. Christopher Schilling, Geno CEO says: “Now, more than ever, global brands are taking […]

July 20, 2022 - 3 minutesmins - By Liza Laws

News and Trends 20 Jul 2022

Business looks to grow life sciences sector in China

A Shanghai business says its top priority is to carry on contributing to the rapid growth of the life sciences sector in China. The ATLATL Center for Innovation & Research is a biopharma research-based open platform that builds laboratories and office spaces equipped with professional research and development (R&D) services, lab facilities and operations management. […]

July 20, 2022 - 3 minutesmins - By Liza Laws

researchers in lab; biotech collaboration

News and Trends 20 Jul 2022

LabShares Newton doubles space for biotech startups and launches pitch contest

LabShares Newton has opened 19,000 square feet of new incubator lab space for startup biotechs and expects to open another 6,000-foot lab in September. LabShares’ new space incorporates 12 private suites, 15 lab benches in the open lab, and a comprehensive set of shared resources and equipment. All private suites have already been committed to […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 20 Jul 2022

ICL and PlantArcBio look to use RNAi to boost crop yields

ICL, a global specialty minerals company, and ag-biotech company PlantArcBio, Ltd., have announced the development of a novel bio-stimulant technology platform to improve crop yields while having a minimal impact on the environment. The platform uses RNAi (RNA interference) technology to maximize a plant’s natural yield increase mechanisms, without any genetic modification, and was the […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

Best in Biotech 20 Jul 2022

The top five organizations using Web3 to solve biotech challenges

As excitement grows over blockchain technology and the decentralized model of Web3 apps, decentralized autonomous organizations (DAOs) are entering the limelight. Check out our list of the five most advanced DAOs aiming to change the game in the biotech industry. For decades, the biotech industry has operated in centralized models. Typically, academics research a disease […]

July 20, 2022 - 6 minutesmins - By Jonathan Smith

Inside Labiotech 20 Jul 2022

Connecting the R&D ecosystem: 150 days into the integration of Inova, IN-PART and Labiotech

Hear from the leadership teams at Inova, IN-PART and Labiotech about how the integration of the three companies is taking shape and the impacts it will have on the R&D ecosystem. The acquisition of IN-PART and Labiotech by Inova in January signaled the intent and ambition to combine the efforts of three companies focused on […]

July 20, 2022 - 5 minutesmins - By External Contributor

News and Trends 20 Jul 2022

WuXi Biologics to build new center in Singapore as part of $1.4B investment

WuXi Biologics, a global contract research, development and manufacturing organization (CRDMO), has announced a 10-year $1.4 billion investment plan. The plan aims to expand the company’s research, development, and large-scale drug substance and drug product (DS/DP) manufacturing capacity and capabilities in Singapore. The company will build a new site that will add 120,000L biomanufacturing capacity […]

July 20, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vicebio exits stealth to work on next generation RSV vaccine

IVI and Moderna sign MOU for vaccine R&D

BigHat Biosciences raises $75M to design safer, more effective antibodies

Upstaza gets nod from Europe for AADC deficiency treatment

Iron protein can now be captured thanks to technology developed by NaviGo

Plant-based nylon addressing urgent need for sustainable materials

Business looks to grow life sciences sector in China

LabShares Newton doubles space for biotech startups and launches pitch contest

ICL and PlantArcBio look to use RNAi to boost crop yields

The top five organizations using Web3 to solve biotech challenges

Connecting the R&D ecosystem: 150 days into the integration of Inova, IN-PART and Labiotech

WuXi Biologics to build new center in Singapore as part of $1.4B investment

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!